About Pricing FAQs Providers Trials Blog

Back to your record

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Ovarian Cancer Clinical Trials in Texas | 750 Studies

Clinical Trials Ovarian CancerTexas

Ovarian Cancer Clinical Trials in Texas

Find 750 clinical trials for ovarian cancer near Texas. Connect with research centers in your area.

All Ovarian Cancer trials nationwide All trials in Texas

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 361-380 of 750 trials

TerminatedA Study to Evaluate Rucaparib in Combination With Other Anticancer Agents in Participants With a Solid Tumor (SEASTAR)This is an open label, Phase 1b/2 study with multiple treatment arms evaluating the safety, tolerability, pharmacokinetics (PK), and preliminary efficacy of rucaparib in…NCT03992131·Boston, Massachusetts and 2 others CompletedStudy of Oral PXD101 in Patients With Advanced Solid Tumors or LymphomaThis is a Phase I dose escalation study of PXD101 administered orally. Oral belinostat will be given once or twice daily at various dosing schedules to patients with solid tumors.NCT00413075·New Haven, Connecticut and 5 others CompletedInterleukin-12 in Treating Patients With Ovarian Epithelial Cancer or Primary Peritoneal CancerPhase II trial to study the effectiveness of intraperitoneal interleukin-12 in treating patients who have ovarian epithelial cancer or primary peritoneal cancer.NCT00016289·Houston, Texas RecruitingRinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)This study will test the safety, including side effects, and determine the characteristics of a drug called Rina-S in participants with solid tumors.NCT05579366·Phoenix, Arizona and 66 others

Ovarian Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

TerminatedYKL-40 in Serum Samples From Patients With Newly Diagnosed Stage III-IV Ovarian Epithelial, Primary Peritoneal Cavity, or Fallopian Tube Cancer Receiving ChemotherapyThis research trial studies chitinase 3-like 1 (cartilage glycoprotein-39) (YKL-40) in serum samples from patients with newly diagnosed stage III-IV ovarian epithelial, primary…NCT00899093·Mobile, Alabama and 130 others

CompletedSGI-110 in Combination With Carboplatin in Ovarian CancerA 2-part, Phase 2 controlled, open-label, randomized study in participants with platinum-resistant recurrent ovarian cancer.NCT01696032·Los Angeles, California and 23 others

CompletedA Study of the Safety, Tolerability, and Efficacy of Epacadostat Administered in Combination With Nivolumab in Select Advanced Cancers (ECHO-204)This is a Phase 1/2, open label study. Phase 1 consists of 2 parts.NCT02327078·Birmingham, Alabama and 23 others

CompletedStudy of Ramucirumab in Ovarian CancerThe purpose of this study is to determine if ramucirumab given as monotherapy is effective in the treatment of Persistent or Recurrent Epithelial Ovarian, Fallopian Tube, or…NCT00721162·Hollywood, Florida and 12 others

CompletedFactors Influencing Cascade Testing Among Women With Hereditary Gynecological Cancers and Their RelativesThis trial collects information about factors that affect communication of genetic test results, decision-making, and access to genetic testing in women with hereditary…NCT04257045·Birmingham, Alabama and 1 other

TerminatedJavelin Parp Medley: Avelumab Plus Talazoparib In Locally Advanced Or Metastatic Solid TumorsAvelumab in combination with talazoparib will be investigated in patients with locally advanced (primary or recurrent) or metastatic solid tumors, including non-small cell lung…NCT03330405·Fayetteville, Arkansas and 65 others

CompletedStudy of AMG 650 in Adult Participants With Advanced Solid TumorsTo evaluate the safety and tolerability of AMG 650 in adult participants and to determine the maximum tolerated dose (MTD) and/or recommended phase 2 dose (RP2D).NCT04293094·Los Angeles, California and 21 others

RecruitingDose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid TumorsThis study is designed to characterize the safety, tolerability, and anti-tumor activity of MDX2001 in patients with advanced solid tumors.NCT06239194·Denver, Colorado and 5 others

RecruitingHeated Intraperitoneal Chemotherapy Followed by Niraparib for Ovarian, Primary Peritoneal and Fallopian Tube CancerPatients will be registered prior to, during or at the completion of neoadjuvant chemotherapy given per standard institutional guidelines +/- bevacizumab on Day 1 every 21 days…NCT05659381·Duarte, California and 58 others

RecruitingLead-212 PSV359 Therapy for Patients With Solid TumorsPhase I/IIa image-guided, alpha-particle therapy study of \[203Pb\]Pb-PSV359 and \[212Pb\]Pb-PSV359 in patients with solid tumors that are known to be Fibroblast Activation…NCT06710756·Los Angeles, California and 15 others

CompletedCOM902 (A TIGIT Inhibitor) in Subjects With Advanced MalignanciesPhase 1 open label sequential dose escalation and cohort expansion study evaluating the safety, tolerability and preliminary antitumor activity of COM902 as monotherapy and in…NCT04354246·Sarasota, Florida and 8 others

CompletedA Phase 1 Study to Evaluate MEDI4736 in Combination With TremelimumabThis was a Phase 1, open-label, nonrandomized, multicenter study of durvalumab and tremelimumab in subjects with advanced cancers who were not eligible for, declined, or failed…NCT01975831·New Haven, Connecticut and 5 others

RecruitingFirst-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid TumorsStudy STX-478-101 (LY4064809) is a multipart, open-label, phase 1/2 study evaluating the safety, tolerability, pharmacokinetics (PK), and preliminary antitumor activity of STX-478…NCT05768139·Los Angeles, California and 64 others

Recruiting177Lu-BetaBart in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid TumorsThis is a Phase 1/2a dose escalation and expansion study to determine the safety, tolerability, and preliminary clinical activity of 177LuBetaBart, a lutetium-labeled anti-B7-H3…NCT07189871·Dothan, Alabama and 4 others

TerminatedA Study Of Avelumab In Combination With Other Cancer Immunotherapies In Advanced Malignancies (JAVELIN Medley)This is a Phase 1b/2 dose-optimization study to evaluate safety, pharmacokinetics, pharmacodynamics, and preliminary antitumor activity of avelumab (MSB0010718C) in combination…NCT02554812·Encinitas, California and 87 others

RecruitingStudy of AVZO-021 in Patients With Advanced Solid TumorsThis study, the first clinical trial of AVZO-021, aims to determine the safety, tolerability, pharmacokinetics, pharmacodynamics, maximum tolerated dose, and anti-tumor effects of…NCT05867251·New Haven, Connecticut and 12 others

PreviousPage 19 of 38Next

Other Conditions in Texas

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia